Hepatitis Monthly

Published by: Kowsar

Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey

Pinar Korkmaz 1 , * , Nese Demirturk 2 , Ayse Batırel 3 , Ahmet Cem Yardimci 4 , Unal Cagir 5 , Salih Atakan Nemli 6 , Fatime Korkmaz 7 , Fusun Zeynep Akcam 8 , Huseyin Sener Barut 9 , Burcu Bayrak 10 , Faruk Karakecili 11 , Huseyin Tarakci 12 , Zerrin Yulugkural 13 , Esma Yuksel 14 , Nazlım Aktug Demir 15 , Onur Ural 15 , Sua Sumer 15 , Rezan Harman 16 , Ayten Kadanali 17 , Sinan Ozturk 17 , Sila Cetin Akhan 18 , Necla Eren Tulek 19 , Derya Keten 20 , Alper Sener 21 , Bilgehan Aygen 22 , Aysel Kocagul Celikbas 23 , Fatma Yilmaz Karadag 24 , Gule Aydin 25 , Eyup Arslan 26 , Cahide Sacligil 27 , Gulfem Akengin Ocal 27 , Alpaslan Tanoglu 28 , Asim Ulcay 29 , Ergenekon Karagoz 29 , Nese Saltoglu 30 , Fatma Sırmatel 31 , Hayrettin Akdeniz 31 , Aynur Aynıoglu 32 , Selcan Arslan Ozel 33 , Selmin Dirgen Caylak 34 , Ilhami Celik 35 , Yesim Alpay 36 , Zehra Bestepe Dursun 35 , Muhammed Bekcibasi 37 , Gunay Tuncer Ertem 19 , Arzu Tigli 38 , Elif Sargin Altunok 39 , Kemal Avsar 38 , Kaya Suer 40 and Murat Sayan 41
Authors Information
1 Dumlupinar University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Kutahya, Turkey
2 Afyon Kocatepe University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Afyon, Turkey
3 Kartal Dr. Lutfi Kırdar Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
4 Sanliurfa Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Sanlıurfa, Turkey
5 Nevsehir State Hospital, Department of Infectious Diseases and Clinical Microbiology, Nevsehir, Turkey
6 Izmir Katip Celebi University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
7 Konya Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Konya, Turkey
8 Suleyman Demirel University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Isparta, Turkey
9 Gaziosmanpasa University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Tokat, Turkey
10 Istanbul Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
11 Erzincan University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Erzincan, Turkey
12 Izmir Metropolitan Municipality Esrefpasa State Hospital, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
13 Trakya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Edirne, Turkey
14 Karsikaya State Hospital, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
15 Selcuk University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Konya, Turkey
16 Private Sanko Hospital, Department of Infectious Diseases and Clinical Microbiology, Gaziantep, Turkey
17 Health Sciences University Umraniye Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
18 Kocaeli University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
19 Ankara Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey
20 Kahramanmaras Necip Fazıl City Hospital, Department of Infectious Diseases and Clinical Microbiology
21 Canakkale Onsekiz Mart University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Canakkale, Turkey
22 Erciyes University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Kayseri, Turkey
23 Ankara NumuneTraining and Research Hospital, Department of Infectious Diseases and Clinical Microbiology,Ankara, Turkey
24 Istanbul Medeniyet University Goztepe Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
25 Afyon State Hospital, Department of Infectious Diseases and Clinical Microbiology, Afyon, Turkey
26 Diyarbakir Selahaddin Eyyubi State Hospital, Department of Infectious Diseases and Clinical Microbiology, Diyarbakır, Turkey
27 Kartal Yavuz Selim State Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
28 Istanbul Sultan Abdulhamid HanTraining Hospital, Department of Gastroenterology, Istanbul, Turkey
29 Istanbul Sultan Abdulhamid Han Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
30 Cerrahpasa University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
31 Abant Izzet Baysal University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bolu, Turkey
32 Zonguldak Ataturk State Hospital, Department of Infectious Diseases and Clinical Microbiology, Zonguldak, Turkey
33 Derince Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Kocaeli, Turkey
34 Mugla Sıtkı Koçman University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Mugla, Turkey
35 Kayseri Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Kayseri, Turkey
36 Balikesir University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Balikesir, Turkey
37 Bismil StateHospital, Department of Infectious Diseases and Clinical Microbiology, Diyarbakır, Turkey
38 Isparta State Hospital, Department of Infectious Diseases and Clinical Microbiology, Isparta, Turkey
39 Bitlis State Hospital, Department of Infectious Diseases and Clinical Microbiology, Bitlis, Turkey
40 Yakın Dogu University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Nicosia, TRNC
41 Kocaeli University Faculty of Medicine, Department of Microbiology, Kocaeli, Turkey, Near East University, Research Center of Experimental Health Sciences, Nicosia, Northern Cyprus
Article information
  • Hepatitis Monthly: December 2017, 17 (12); e60266
  • Published Online: July 23, 2017
  • Article Type: Research Article
  • Received: October 30, 2016
  • Accepted: July 1, 2017
  • DOI: 10.5812/hepatmon.60266

To Cite: Korkmaz P, Demirturk N, Batırel A, Cem Yardimci A, Cagir U, et al. Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey, Hepat Mon. 2017 ; 17(12):e60266. doi: 10.5812/hepatmon.60266.

Abstract
Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. [PubMed: 22436845].
  • 2. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005;42(6):1437-45. doi: 10.1002/hep.20960. [PubMed: 16317674].
  • 3. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32(3):477-81. doi: 10.1053/jhep.2000.16602. [PubMed: 10960438].
  • 4. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol. 2003;38(4):427-32. [PubMed: 12739716].
  • 5. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614-8. doi: 10.1111/j.1572-0241.2002.06038.x. [PubMed: 12385448].
  • 6. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006;55(4):569-78. doi: 10.1136/gut.2005.084475. [PubMed: 16531536].
  • 7. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-9. [PubMed: 7560864].
  • 8. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005;42(2):282-92. doi: 10.1002/hep.20772. [PubMed: 15986415].
  • 9. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42 Suppl(1):S22-36. doi: 10.1016/j.jhep.2004.12.008. [PubMed: 15777570].
  • 10. Hsieh YY, Tung SY, Lee K, Wu CS, Wei KL, Shen CH, et al. Routine blood tests to predict liver fibrosis in chronic hepatitis C. World J Gastroenterol. 2012;18(8):746-53. doi: 10.3748/wjg.v18.i8.746. [PubMed: 22371634].
  • 11. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92(8):1302-4. [PubMed: 9260794].
  • 12. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat. 1997;4(3):199-208. [PubMed: 9181529].
  • 13. Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, et al. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci. 1999;44(6):1249-53. [PubMed: 10389705].
  • 14. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-26. doi: 10.1053/jhep.2003.50346. [PubMed: 12883497].
  • 15. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-25. doi: 10.1002/hep.21178. [PubMed: 16729309].
  • 16. Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS One. 2013;8(7). e68780. doi: 10.1371/journal.pone.0068780. [PubMed: 23874760].
  • 17. Lee IC, Chan CC, Huang YH, Huo TI, Chu CJ, Lai CR, et al. Comparative analysis of noninvasive models to predict early liver fibrosis in hepatitis B e Antigen-negative Chronic Hepatitis B. J Clin Gastroenterol. 2011;45(3):278-85. doi: 10.1097/MCG.0b013e3181dd5357. [PubMed: 20505530].
  • 18. Kekilli M, Tanoglu A, Sakin YS, Kurt M, Ocal S, Bagci S. Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?. World J Gastroenterol. 2015;21(18):5575-81. doi: 10.3748/wjg.v21.i18.5575. [PubMed: 25987782].
  • 19. Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, et al. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006;26(6):666-72. doi: 10.1111/j.1478-3231.2006.01287.x. [PubMed: 16842322].
  • 20. Guzelbulut F, Sezikli M, Akkan-Cetinkaya Z, Yasar B, Ozkara S, Kurdas-Ovunc AO. AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B. Turk J Gastroenterol. 2012;23(4):353-8. [PubMed: 22965506].
  • 21. Erdogan S, Dogan HO, Sezer S, Uysal S, Ozhamam E, Kayacetin S, et al. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients. Scand J Clin Lab Invest. 2013;73(4):300-8. doi: 10.3109/00365513.2013.773592. [PubMed: 23514016].
  • 22. Celikbilek M, Dogan S, Gursoy S, Zararsiz G, Yurci A, Ozbakir O, et al. Noninvasive assessment of liver damage in chronic hepatitis B. World J Hepatol. 2013;5(8):439-45. doi: 10.4254/wjh.v5.i8.439. [PubMed: 24023983].
  • 23. Teshale E, Lu M, Rupp LB, Holmberg SD, Moorman AC, Spradling P, et al. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat. 2014;21(12):917-20. doi: 10.1111/jvh.12279. [PubMed: 25131445].
  • 24. Eminler AT, Ayyildiz T, Irak K, Kiyici M, Gurel S, Dolar E, et al. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. Eur J Gastroenterol Hepatol. 2015;27(12):1361-6. doi: 10.1097/MEG.0000000000000468. [PubMed: 26352130].
  • 25. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61(1):292-302. doi: 10.1002/hep.27382. [PubMed: 25132233].
  • 26. Halazun KJ, Hardy MA, Rana AA, Woodland D, Luyten EJ, Mahadev S, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009;250(1):141-51. doi: 10.1097/SLA.0b013e3181a77e59. [PubMed: 19561458].
  • 27. Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32(2):297-302. doi: 10.1111/j.1478-3231.2011.02639.x. [PubMed: 22097893].
  • 28. Yesil A, Cosgun S, Erdem E, Kochan K, Gunduz F, Gonen C. The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in chronic HBV patients. Age. 2013;38(13):37-14.
  • 29. Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One. 2012;7(5). e37644. doi: 10.1371/journal.pone.0037644. [PubMed: 22649548].
  • 30. Taefi A, Huang CC, Kolli K, Ebrahimi S, Patel M. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol Int. 2015;9(3):454-60. doi: 10.1007/s12072-015-9638-9. [PubMed: 26088296].
  • 31. Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. Eur J Gastroenterol Hepatol. 2013;25(4):428-34. doi: 10.1097/MEG.0b013e32835cb5dd. [PubMed: 23358121].
  • 32. Zeng X, Xu C, He D, Li M, Zhang H, Wu Q, et al. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B. Croat Med J. 2015;56(3):272-9. [PubMed: 26088852].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments